How sleep connects to diabetes, blood pressure, and memory in diverse Hispanic/Latino adults

Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/Latinos

NIH-funded research Beth Israel Deaconess Medical Center · NIH-11129850

This project uses blood and DNA markers to find links between sleep problems and risks for diabetes, high blood pressure, and memory loss in Hispanic/Latino adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11129850 on NIH RePORTER

What this research studies

This work uses sleep measurements and stored biological samples from the long-running Hispanic Community Health Study/Study of Latinos (HCHS/SOL), which followed about 16,500 people from multiple Latino backgrounds. Researchers will look for metabolomics and DNA methylation patterns tied to different sleep traits and then study how those patterns relate to diabetes, hypertension, and cognitive decline. They will also connect molecular signals to lifestyle and sociocultural factors to find modifiable risks. The team aims to combine these signals into biomarkers that could help identify who is at higher risk because of poor sleep.

Who could benefit from this research

Good fit: Ideal candidates mirror the HCHS/SOL cohort: Hispanic/Latino adults, especially those with sleep problems or with diabetes, hypertension, or early memory concerns.

Not a fit: People without sleep issues, non-Hispanic/Latino individuals, or those from groups not represented in the cohort may not gain direct benefit from the findings.

Why it matters

Potential benefit: If successful, the project could produce blood-based markers that help detect people whose sleep increases their chance of diabetes, high blood pressure, or cognitive decline so prevention can start earlier.

How similar studies have performed: Prior studies have linked sleep problems to metabolic and cognitive outcomes and found small metabolomic or methylation signals, but applying multiple omics in a large, diverse Latino cohort is relatively new.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.